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Abstract 
Purpose: Premorbid conditions affect prognosis of acutely-ill aged patients. Several lines of evidence suggest geriat-
ric syndromes need to be assessed but little is known on their relative effect on the 30-day survival after ICU admis-
sion. The primary aim of this study was to describe the prevalence of frailty, cognition decline and activity of daily life 
in addition to the presence of comorbidity and polypharmacy and to assess their influence on 30-day survival.
Methods: Prospective cohort study with 242 ICUs from 22 countries. Patients 80 years or above acutely admitted 
over a six months period to an ICU between May 2018 and May 2019 were included. In addition to common patients’ 
characteristics and disease severity, we collected information on specific geriatric syndromes as potential predic-
tive factors for 30-day survival, frailty (Clinical Frailty scale) with a CFS > 4 defining frail patients, cognitive impairment 
(informant questionnaire on cognitive decline in the elderly (IQCODE) with IQCODE ≥ 3.5 defining cognitive decline, 
and disability (measured the activity of daily life with the Katz index) with ADL ≤ 4 defining disability. A Principal Com-
ponent Analysis to identify co-linearity between geriatric syndromes was performed and from this a multivariable 
model was built with all geriatric information or only one: CFS, IQCODE or ADL. Akaike’s information criterion across 
imputations was used to evaluate the goodness of fit of our models.
Results: We included 3920 patients with a median age of 84 years (IQR: 81–87), 53.3% males). 80% received at least 
one organ support. The median ICU length of stay was 3.88 days (IQR: 1.83–8). The ICU and 30-day survival were 72.5% 
and 61.2% respectively. The geriatric conditions were median (IQR): CFS: 4 (3–6); IQCODE: 3.19 (3–3.69); ADL: 6 (4–6); 
Comorbidity and Polypharmacy score (CPS): 10 (7–14). CFS, ADL and IQCODE were closely correlated. The multivari-
able analysis identified predictors of 1-month mortality (HR; 95% CI): Age (per 1 year increase): 1.02 (1.–1.03, p = 0.01), 
ICU admission diagnosis, sequential organ failure assessment score (SOFA) (per point): 1.15 (1.14–1.17, p < 0.0001) and 
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Introduction
The number of very old patients admitted to the intensive 
care unit (ICU) is rising, which parallels the increase in 
the proportion of elderly people in most developed coun-
tries [1]. In the past decade this has been identified as a 
potential health challenge because these patients aged 
80 and above consume a disproportionally large part of 
the health care budget, while the mortality rates are con-
sistently reported to be higher than in younger patients 
[2]. However, it is important to separate unplanned from 
planned ICU admissions, since the latter group has a 
much better outcome [3]. In unplanned admissions the 
overall 30-day mortality of ICU patients is approximately 
40% [4]. Long-term mortality (6 months or 12 months) is 
most often 50% or above [5]. This high mortality trans-
lates into suffering in patients and relatives and moral 
distress in care-givers. It is, therefore, of utmost impor-
tance to better identify elderly patients with an expected 
good outcome including a post discharge acceptable 
quality of life.
Previous research has shown that age and severity 
of illness at admission only partly explain the chance 
of survival of elderly patients and traditional prognos-
tic scoring systems are often inaccurate [6]. In the very 
old patients the ability to cope with severe stressors like 
critical illness seems to be more related with the geriatric 
syndromes, like frailty [4], cognitive decline [7, 8] and a 
reduced performance on the activity of daily life (ADL) 
scale in addition to comorbidity. However, the impact 
and relationship of this premorbid functioning on the 
outcome of acutely admitted elderly ICU patients have 
not been established [7, 8].
In this study, using the European Very elderly Intensive 
Patient (VIP) network, our primary aim was to document 
the prevalence of three common geriatric syndromes: 
frailty, cognitive impairment and disability in addition to 
the presence of comorbidity and polypharmacy, and to 
assess their influence on 30 days’ survival.
Methods
Design and setting
This was a prospective observational study in 242 ICUs 
from 20 European countries, plus Turkey and Libya. The 
participating ICU characteristics were: mean number of 
beds: 15; mean number of ICU admission in year 2017: 
955; percentage of patients 80 years of age or older admit-
ted in 2017: 17%. Each participating ICU is listed in elec-
tronic supplement material (ESM1) and recruitment per 
country is presented in ESM2. The inclusion period was 
from May 2018 to May 2019. Most of the patients were 
included during the 2018–2019 winter season (ESM3). 
The 30-day follow-up ended on July 15 2019.
The study was coordinated through the health services 
resource and outcome (HSRO) section of the European 
society of intensive care medicine (ESICM). Each coun-
try had a national coordinator (NC) responsible for ICU 
recruitment and application for national or regional ethi-
cal and regulatory study approval. Institutional research 
ethic board approval was obtained from each study site. 
Five countries were allowed to recruit patients without 
prior written informed consent while others had to col-
lect informed consent from patient or their legal rep-
resentative [9]. Individual ICUs were asked to include 
consecutive patients for a 6-month period in the 1-year 
study period and were allowed to stop after 20 included 
patients. All patients were followed until 30  days after 
ICU admission. A dedicated web site (www.VIP2s tudy.
com) was set up to facilitate information about the 
study and study progress and to allow for data entry 
using an electronic case record form CRF (supplemen-
tal 1). The study is registered on ClinicalTrials.gov (ID: 
NCT03370692). There was no specific funding except an 
ESICM award received by HF.
CFS (per point): 1.1 (1.05–1.15, p < 0.001). CFS remained an independent factor after inclusion of life-sustaining treat-
ment limitation in the model.
Conclusion: We confirm that frailty assessment using the CFS is able to predict short-term mortality in elderly 
patients admitted to ICU. Other geriatric syndromes do not add improvement to the prediction model. Since CFS is 
easy to measure, it should be routinely collected for all elderly ICU patients in particular in connection to advance care 
plans, and should be used in decision making.
Keywords: Critical care, Outcome, Prediction, Elderly, Frailty, Cognitive functioning, Activities of daily living, 
Comorbidity
Take‑home message 
In this prospective multinational study of 3920 very old intensive 
care patients (≥ 80 years), clinical frailty scale alone described geriat-
ric syndromes. Cognition and activity of daily life did not add to the 
prediction model for 1-month survival after ICU admission.
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Participants
Only emergency (acute) ICU admissions in 
patients ≥ 80  years of age were eligible. All reasons for 
acute ICU admissions were accepted.
Data collection
Data collection at admission
For each eligible patient, demographic data were col-
lected: age, sex, place of living before admission to the 
hospital, and reason for admission according to a prede-
fined list (ESM4).
Second, the study collected mandatory data on the 
patient’s geriatric conditions prior to this hospital admis-
sion, including the clinical frailty scale (CFS) [10]. For the 
assessment of frailty, we defined the frailty level present 
before hospital admission and not affected by the acute 
illness. The information necessary to perform this assess-
ment were given by patients or proxy or patient records, 
and the assessor’s profession was reported. The Clinical 
Frailty Scale visual and with simple description were used 
with permission (ESM5) [10]. The scale is composed of 
9 classes from very fit to terminally ill. Prefrail patients 
have a CFS of 4, while frail patients have a CFS of 5 or 
above. We also recorded Katz activities of daily living 
(Katz ADL) (ESM6) [11] with ADL score ≤ 4 defining 
disability. Short form of Informant Questionnaire on 
Cognitive Decline in the Elderly (IQCODE) [12] (ESM7) 
was used. The information to calculate the IQCODE 
was given by caregivers with intimate knowledge of 
the patient for the past 10  years. We defined cognitive 
decline as an IQCODE ≥ 3.5 [13]. Comorbidity and poly-
pharmacy score (CPS) were calculated [14]. A CPS above 
15 was considered as high.
Data collection of variables during ICU admission
Within the first 24  h of ICU admission the sequential 
organ failure assessment (SOFA) score was calculated 
[15]. The total SOFA score on admission was calculated 
using an online calculator in the eCRF. Length of ICU 
stay (LOS) was recorded as the number of hours between 
admission and discharge and latter converted to days in 
the analysis. Any period on non-invasive, invasive (with 
endotracheal intubation or tracheotomy) mechanical 
ventilation, use of vasoactive drugs and renal replace-
ment therapy was registered with start (ICU day) and 
duration of the treatment (in hours).
Limitation of life sustaining therapies (LST) such as 
withholding or withdrawing life-supporting treatments 
was documented as performed and on which ICU day, or 
if not performed [16].
Outcome was measured as survival in the ICU and 
30  days after ICU admission with information on the 
day of death after ICU admission. Information source for 
vital status at day 30 was documented.
The Case Record Form and database were hosted on a 
secure server located on the campus of Aarhus Univer-
sity, Denmark.
Bias
The ICUs were asked to include all acutely admitted, con-
secutive patients irrespective of the estimated duration of 
ICU stay.
Study size
We had no formal calculation in this purely observational 
study. We estimated a 30-day mortality of 40% in a simi-
lar population [17].
Statistical analysis
Baseline characteristics of patients were analyzed as fre-
quencies and percentages for categorical variables and as 
medians and interquartile ranges (IQRs) for continuous 
variables.
Principal Component Analysis (PCA) was used to 
represent the variation present in the dataset and show 
association between geriatric and severity variables (age, 
SOFA score, CPS, IQ code, Katz’s scale and clinical frailty 
scale). For visual analysis, two-dimensional projection of 
the sample was constructed having the axes (principal 
components, PC) as the factors. Each PC is a linear com-
bination of the original variables (that retain some corre-
lation among each other) and PCs are orthogonal to each 
other.
The crude overall survival at 30 days was estimated by 
the Kaplan–Meier method and compared using a log-
rank test. We used multiple imputations for participants 
with missing data, using predictive mean matching for 
continuous variables, logistic regression for binary data, 
and polynomial regression for (unordered) categorical 
data. The cumulative baseline hazard was approximated 
by the Nelson-Aalen estimator and included in the impu-
tation model. Five imputations were drawn.
Multivariable analyses were performed using the 
Cox proportional hazards model for overall survival at 
30  days. All patients’ characteristics listed in the CRF 
were included in our models including LST limitation. 
We used mean Akaike’s information criterion (AIC) 
across imputations to evaluate the goodness of fit of 
our models. AIC = − 2 Log likelihood + 2p, where p is 
the number of parameters [18]. Models with lower AIC 
are interpreted as models that best fit the data. Last, we 
included limitation decisions as a time-dependent vari-
able to test whether geriatric parameters kept their prog-
nostic value. Hazard ratio (HR) given by the Cox model 
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describe the relative risk of death based on comparison 
of event rates in different groups. HR gives the change in 
risk of death per each unit increase for continuous varia-
bles and for one specific category versus a reference cate-
gory for categorical variables. HR > 1 suggests an increase 
in the risk of death, HR < 1 suggest a decrease in the risk 
of death. A Cox model was used to analyze treatment 
limitation as a time to event variable.
Adjusted survival curves were produced using an 
inverse probability-weighted Kaplan–Meier estima-
tion [19]. Significance was tested using a Cox regression 
model weighted by the same weights (inverse probabil-
ity-weighted Cox). Inter-rater variability for assessing 
Clinical Frailty Scale was analyzed with Med-Calc for 
Windows 15.0 (MedCalc Software, Ostend, Belgium) and 
presented as Weighted kappa [20]. All analyses were per-
formed by AB with R software, version 3.2.2 (R Founda-
tion for Statistical Computing) (packages FactorMineR 
and missMDA for PCA, MICE for multiple imputations, 
survival for survival analysis, ipw for inverse-probability 
weighting, rms for adjusted survival curves).
Results
Participants
We included 3920 patients (median age 84  years) from 
22 countries and 242 ICUs. Most patients lived at home 
without help (72.8%,) or with care-givers (11.1%) before 
being admitted to the hospital. Admissions related to res-
piratory and/or circulatory failures and sepsis (as defined 
by sepsis 3 criteria) accounted for 63.2% of the total 
while emergency surgery represented 13.8% of the total 
admissions. The patients were severely ill as evidenced 
by a median SOFA score of 6 (IQR 4–9) (Table 1). Most 
patients had at least one organ support (Table  2). The 
median ICU LOS was 3.9 days (IQR: 1.83–8).
No difference was found in patients’ characteristics 
in ICUs with a recruitment period above vs. below the 
median of 60  days (ESM8) ruling out possible bias due 
to different recruitment times. Recruitment per ICU was 
excellent (ESM9) but patients included in countries with 
no need for informed consent were sicker with a SOFA 
score almost two points higher (ESM10).
The geriatric syndromes (Tables  1,  3) were as fol-
lows: Median (IQR): CFS: 4 (3–6) with only 17 miss-
ing values. Information to assess CFS was given by the 
patient in 29.7% (1159/3901) and by the family in 51.7% 
(2016/3901). The professional assessor was an ICU physi-
cian (59.8%, 2335/3901), an ICU nurse (13.7%, 535/3901) 
or research staff (23.7%, 925/3901). CPS values were 
similar when measured by different assessors (ESM11). 
The CFS was measured by two different raters in 1924 
individuals. The weighted Kappa was 0.85 (95%CI 0.84–
0.87) which is excellent (ESM12).
Frailty (CFS ≥ 5) was present in 40.2% (1568/3903). 
IQCODE was 3.19 (3–3.69) with 940/3920 (24%) miss-
ing values. Patients with missing values of IQCODE 
were different from patients with documented IQCODE 
(ESM123). IQCODE above 3.5 indicating a cognitive 
decline was observed in 30.2%. Katz ADL was 6 (4–6) 
with 447/3920 (11.4%) missing values. An ADL of 4 or 
less, as a marker of functional decline was observed in 
27.7% (962/3473). Comorbidity and polypharmacy score 
(CPS) was 10 (7–14) with 8/3920 (0.2%) missing values. 
A CPS above 15 was present in 17.7% (693/3912) of the 
patients.
Outcome data
LST limitations were documented in 34.4% (1332/3872) 
including withholding in 29.4% (1140/3872) of patients 
with a decision made at day 1 (IQR 1–4) and treatment 
withdrawal (with or without prior withholding) in 14% 
(545/3872) with a median decision time of 4  days (IQR 
2–7) after ICU admission. Patients with LST limitation 
were frailer and more severely ill compared to patients 
with no LST limitation (Table 4). The multivariable anal-
ysis identified age, habitat, SOFA score, CPS and CFS 
as independent factors predicting decision to limit LST 
(Table 5).
The ICU and 30-day vital status were, respectively, 
available for 3900/3920 (99.9%) and 3841/3920 (99.4%) 
patients. The vital status was assessed by checking the 
hospital records (81.4%, 2780/3415), direct contact with 
the patient (12.3%, 420/3415) or checking a national reg-
istry (3.3%, 111/3415).
The overall proportion of patients surviving ICU was 
72.5% (2828/3900). Survival after ICU admission was 
96.3% at day one (95.7–96.9), 74.2% (72.8–75.6) at day 10, 
65.9% (64.5–67.5) at day 20 and 61.2% (59.7–62.7) at day 
30.
Predictive factors for 30‑day survival
In our PCA analysis the first two PC explain as much 
as 56.79% of the total variation in the sample; the anal-
ysis was restricted to these first two dimensions. PC1 
retained 39% of data variation and differentiates the indi-
viduals according to Katz ADL, Clinical Frailty Scale and 
IQCODE. Similarly, PC2 explained another 18% of vari-
ability in the original data and separates the individuals 
based on severity (SOFA) and age. Figure  1 represents 
the projection of variables on the factor-plane and shows 
correlation between the three geriatric syndromes IQ 
code, Katz ADL and Clinical Frailty Scale. Except for 
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CPS, each geriatric syndrome had impact on 1-month 
survival (Fig. 2).
The multivariable analysis identified the usual predic-
tors of 30-day outcome (HR; 95% CI): Age (increase in 
risk of death per 1 year increase): 1.02 (1–1.03, p = 0.01), 
ICU admission diagnosis, SOFA (increase in risk of death 
per one-point increase): 1.15 (1.14–1.17, p < 0.0001) and 
CFS (increase in risk of death per one point increase): 1.1 
(1.05–1.15, p < 0.001). The model including all geriatric 
parameters did not perform better than the model with 
CFS only (Table 6). The CPS was not independently asso-
ciated with 30-day outcome. When including limitation 
decision as a time-dependent variable in the model, CFS 
still has a prognostic impact on survival with an increase 
in the risk of death per each unit increase of CFS of 1.08 
(1.05–1.12, p < 0.001) (Table 7).
Discussion
In the ICU community there is a growing need for evi-
dence and guidelines to ease the decision-making process 
for an informed ICU admission in the very old including 
ICU triage, and this should be supported by best available 
evidence [21]. In that perspective, this large prospective 
study of non-scheduled, acute ICU admissions provides 
important information.
We confirmed that 30-day survival is very low (61.2%) 
in unselected patients 80 years or older who are acutely 
admitted to the ICU. Age-related symptoms as frailty, 
Table 1 Patients characteristics
Vital status was assessed 1 month after ICU admission. 79 patients had no vital status reported at 1 month
SOFA sequential organ failure assessment, CFS clinical frailty scale, IQCODE informant questionnaire on cognitive decline in the elderly, ADL activity of daily living, CPS 
Co-morbidity and Polypharmacy score
Variables Categories All Survivors Non survivors p‑value
N 3920 2327 1514
Age Median (range) (IQR) 84 (range: 80–104) (81–87) 84 (range 80–104) (81–87) 84 (range 80–98) (82–87) 0.04
Gender Male 2089 (53.3%) 1210 (52%) 836 (55.2%) 0.06
Female 1831 (46.7%) 1117 (48%) 678 (44.8%)
Place of living Own home (including if with 
spouse)
2852 (72.8%) 1774 (76.3%) 1031 (68.1%) < 0.0001
Other home with family or 
caregivers
434 (11.1%) 228 (9.8%) 191 (12.6%)
Nursing home 210 (5.4%) 112 (4.8%) 96 (6.3%)
Hospital ward 361 (9.2%) 179 (7.7%) 174 (11.5%)
Other 35 (0.9%) 22 (0.9%) 11 (0.7%)
Unknown 27 (0.7%) 11 (0.5%) 11 (0.7%)
Reason for admission Respiratory failure 944 (24.1%) 583 (25.1%) 343 (22.7%) < 0.0001
Circulatory failure 541 (13.8%) 303 (13%) 228 (15.1%)
Combined respiratory/circulatory 
failure
449 (11.5%) 186 (8%) 253 (16.7%)
Sepsis (according to Sepsis3) 539 (13.8%) 287 (12.3%) 239 (15.8%)
Multitrauma without head injury 87 (2.2%) 58 (2.5%) 27 (1.8%)
Multitrauma with head injury 75 (1.9%) 35 (1.5%) 37 (2.4%)
Isolated head injury 71 (1.8%) 33 (1.4%) 38 (2.5%)
Intoxication 23 (0.6%) 17 (0.7%) 6 (0.4%)
Non-traumatic cerebral pathology 190 (4.8%) 103 (4.4%) 84 (5.5%)
Emergency surgery 541 (13.8%) 369 (15.9%) 163 (10.8%)
Other causes 459 (11.7%) 352 (15.1%) 96 (6.3%)
SOFA Median (range) (IQR) 6 (range: 0–20) (4–9) 5 (range 0–18) (3–8) 8 (range 0–20) (5–11) < 0.0001
CFS Median (range) (IQR) 4 (range: 1–9) (3–6) 4 (range 1–9) (3–5) 4 (range 1–9) (3-6) < 0.0001
IQ Code Median (range) (IQR) 3.19 (range: 1–5) (3–3.69) 3.19 (range 1–5) (3–3.56) 3.31 (range 1–5) (3–4) < 0.0001
ADL (Katz) Median (range) (IQR) 6 (range: 0–6) (4–6) 6 (range 0–6) (5–6) 6 (range 0–6) (3–6) < 0.0001
Comorbidities Median (range) (IQR) 4 (range: 0–20) (3–6) 4 (range 0–20) (3–5) 4 (range 0–20) (3–6) 0.013
Drugs taken daily Median (range) (IQR) 6 (range: 0–26) (4–9) 6 (range 0–21) (4–9) 6 (range 0–26) (4–9) 0.17
CPS Median (range) (IQR) 10 (range: 0–36) (7–14) 10 (range 0–36) (7–14) 11 (range 0–35) (7–14) 0.05
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cognitive decline and disability were strongly associated 
with 30-day mortality and were more important than age 
alone. Comorbidity and polypharmacy, however, had no 
predictive value when measured as the CPS. Interest-
ingly, the addition of cognitive impairment and disabil-
ity to the prognostic analysis did not increase prognostic 
value compared with the model with frailty alone. The 
CFS was reported in 99.5% of the cases and the inter-
rater reproducibility was very good confirming that this 
tool is robust and easy to use.
In a previous prospective study in Europe, frailty was 
found to be present in 46% of acute admitted elderly 
ICU patients [4] and was closely related to both ICU and 
30-day mortality. In the present study, frailty remained 
independently associated with both ICU and 30  days 
mortality, and this strengthens its importance in pre-
ICU assessment. Frailty affects several important body 
functions like the endocrine system, brain, muscular and 
immune function, all very important in the ICU context, 
and was recently discussed in a clinical review [22]. The 
link between frailty and health-related quality of life was 
documented in a prospective Canadian study [23]. Frail 
patients were found to report reduced quality of life both 
in the physical and mental subset of EuroQol Health 
Table 2 ICU stay characteristics
Non-survivors are defined by 30-day mortality
Variables Categories All Survivors Non survivors p‑value
N 3920 2327 1514
Intubation Yes 1953 (49.9%) 939 (40.4%) 974 (64.5%) < 0.0001
Tracheostomy Yes 264 (6.8%) 168 (7.2%) 90 (6%) 0.14
Non invasive ventilation Yes 903 (23.1%) 547 (23.6%) 342 (22.6%) 0.51
Vaso active drugs Yes 2329 (59.5%) 1169 (50.3%) 1114 (73.6%) < 0.0001
Renal replacement therapy Yes 429 (11%) 163 (7%) 259 (17.1%) < 0.0001
Withholding of treatment Yes 1140 (29.4%) 390 (16.9%) 738 (49.2%) < 0.0001
Withdrawing of treatment Yes 545 (14%) 27 (1.2%) 517 (34.4%) < 0.0001
ICU LOS in days Median (range) (IQR) 3.88 (0.04-30) (1.83-8) 3.67 (0.04-30) (1.92–7.71) 4 (0.04-30) (1.54–8.46) 0.75
ICU survival Missing 13 10 3
Alive 2828 (72.5%) 2285 (98.6%) 471 (31.2%) < 0.0001
30 days’ survival Missing 79
Alive 2346 (61.1%)
Day of death Median (range) (IQR) 7 (0–30)(3–14)
Table 3 Scores assessed as categories
Variables Categories All Survivors Non survivors p‑value
CFS Fit (CFS 1-3) 1544 (39.6%) 1011 (43.5%) 509 (33.9%) < 0.0001
Vulnerable (CFS 4) 791 (20.3%) 483 (20.8%) 287 (19.1%)
Frail (CFS 5-8) 1568 (40.2%) 830 (35.7%) 704 (46.9%)
IQCODE categories  < 3 178 (6%) 125 (6.3%) 48 (5.1%) < 0.0001
3 709 (23.8%) 483 (24.5%) 212 (22.3%)
> 3–3.5 1194 (40.1%) 859 (43.6%) 316 (33.3%)
> 3.5 899 (30.2%) 505 (25.6%) 373 (39.3%)
CPS categories 0–9 1697 (43.4%) 1024 (44%) 644 (42.6%) 0.12
10–15 1522 (38.9%) 913 (39.3%) 575 (38.1%)
> 15 693 (17.7%) 389 (16.7%) 292 (19.3%)
KATZ categories 0–4 962 (27.7%) 500 (22.6%) 441 (36.8%) < 0.0001
5 440 (12.7%) 295 (13.3%) 135 (11.3%)
6 2071 (59.6%) 1417 (64.1%) 623 (52%)
SOFA categories SOFA 0–5 1741 (44.5%) 1304 (56.2%) 410 (27.1%) < 0.0001
6–9 1286 (32.9%) 699 (30.1%) 555 (36.7%)
> 10 882 (22.6%) 317 (13.7%) 547 (36.2%)
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Questionnaire and in the SF-12. The use of the CFS has 
probably expanded lately, and different acute care settings 
find it useful to evaluate elderly patients in such a quick 
manner, even without patient contribution [24–26], mak-
ing it of particular interest in the unresponsive or uncon-
scious patient. There is also an emerging line of research 
trying to link frailty with delirium. Future studies are 
required to investigate the possible link between these 
two factors on ICU survival [27].
Cognitive decline has been found to affect mortality 
in many clinical settings [28, 29] and several methods 
are used to diagnose and assess the severity of cognitive 
decline and dementia. Most of these tests require active 
patient involvement and are, for obvious reasons, not 
Table 4 Patient characteristics according to decision to limit life sustaining treatment: withholding and/or withdrawing
N = 48 patients with missing information on LST limitation (WH/WD)
Variables Categories All No limitation Withdraw and/or withhold p‑value
N 3920 2540 1332
Age Median (range) (IQR) 84 (range: 80–104) (IQR: 
81–87)
83 (range 80–100) (IQR 81–86) 84 (range 80–99) (IQR 82-87) < 0.0001
SOFA Missing 11 3 6
Median (range) (IQR) 6 (range: 0–20) (IQR: 4–9) 6 (range 0–20) (IQR 3–9) 7 (range 0–19) (IQR 5–10) < 0.0001
CFS Missing 17 7 9
Median (range) (IQR) 4 (range: 1–9) (IQR: 3–6) 4 (range 1–9) (IQR 3–5) 4 (range 1–9) (IQR 3–6) < 0.0001
IQ Code Missing 940 504 416
Median (range) (IQR) 3.19 (range: 1–5) (IQR: 3–3.69) 3.19 (range 1–5) (IQR 3–3.57) 3.31 (range 1–5) (IQR 
3.06–3.88)
< 0.0001
Katz Missing 447 219 215
Median (range) (IQR) 6 (range: 0–6) (IQR: 4–6) 6 (range 0–6) (IQR 5–6) 6 (range 0–6) (IQR 4–6) < 0.0001
Comorbidities Missing 7 1 2
Median (range) (IQR) 4 (range: 0–20) (IQR: 3–6) 4 (range 0–20) (IQR 3–5) 4 (range 0–20) (IQR 3–6) 0.005
Drugs daily Missing 8 1 2
Median (range) (IQR) 6 (range: 0–26) (IQR: 4–9) 6 (range 0–21) (IQR 4–8) 7 (range 0–26) (IQR 4–9) < 0.0001
CPS Missing 8 1 2
Median (range) (IQR) 10 (range: 0–36) (IQR: 7–14) 10 (range 0–36) (IQR 7–14) 11 (range 0–35) (IQR 8–5) < 0.0001
ICU LOS in days (all 
patients alive/
dead) 
Missing 11 3 1
Median (range) (IQR) 3.88 (range: 0.04–120) (IQR: 
1.83–8)
3.96 (range 0.04–120) (IQR 
1.96–8)
3.67 (range 0.04–85.5) (IQR 
1.54–7.85)
0.03
Table 5 Multivariate analysis of treatment limitation (Cox model analyzing treatment limitation as a time to event vari‑
able)
Variables Categories HR (95%CI) p‑value
Age One-point increase 1.04 (95% CI 1.03–1.06) < 0.00001
Habitat (ref = not home) Own home 1.27 (95% CI 1.12–1.45) 0.0004
Gender (ref = male) Female 1.08 (95% CI 0.97–1.21) 0.17
Reason for admission (ref = circulatory 
failure)
Combined respiratory/circulatory failure 0.9 (95% CI 0.7–1.11) 0.32
Emergency surgery 0.67 (95% CI 0.5–0.83) 0.0003
Multitrauma with head injury 0.92 (95% CI 0.–1.41) 0.70
Multitrauma without head injury 0.77 (95% CI 0.–1.18) 0.23
Other 0.8 (95% CI 0.6–0.97) 0.02
Respiratory failure 1 (95% CI 0.8–1.19) 0.96
Sepsis (according to Sepsis3) 0.92 (95% CI 0.75–1.12) 0.40
SOFA One-point increase 1.07 (95% CI 1.05–1.09) < 0.00001
CPS One-point increase 1.01 (95% CI 1–1.02) 0.009
CFS One-point increase 1.11 (95% CI 1.08–1.15) < 0.00001
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applicable to patients who are acutely admitted to the 
ICU. Hence, we must rely on information from someone 
close to the patient in order to approach cognitive func-
tion if there is no clear evidence from patient records. The 
IQCODE was developed as a response to such demand 
[30] and has been used frequently as a simple screening 
tool based on information from caregivers. The IQCODE 
has been analyzed in a Cochrane review with regard to its 
accuracy in finding patients with dementia [13]. A thresh-
old of 3.3 had 0.83 sensitivity and 0.80 specificity while a 
threshold of 3.5 had 0.82 sensitivity and 0.84 specificity. 
Studies where IQCODE has been applied prior to ICU 
admission are scarce. An early study of IQCODE com-
pared with Modified Blessed Dementia Rating Scale 
(MBDRS) was performed in 130 ICU patients ≥ 65 years 
[31]. They found that an IQCODE > 3.3 was present in 
31% of their patients. Using the same threshold, we found 
44% having an IQCODE > 3.3, and the higher percentage 
probably mirrors the older age group in our study. With 
a threshold of 3.5; the prevalence of cognitive impair-
ment was 30.2%. In a more recent study from Spain, ICU 
patients were prospectively studied with data on cogni-
tion (IQCODE), activity of daily life, comorbidity and a 
full geriatric assessment in addition to disease severity 
scores [32]. They found parameters related to quality of 
life and functional status to be independently correlated 
with mortality, but not cognitive decline. However, most 
of their patients had IQCODE values within the normal 
range. Although IQCODE did not increase the predictive 
value when added to frailty, it was shown to have impact 
on 30-day outcome. It is possible that other more specific 
measures on cognitive decline would have performed 
better, but such may be difficult to implement in an acute 
setting. Even the IQCODE proved the most difficult 
measure to obtain in our cohort with 24% missing data.
The CPS score is a simple score, which measures the 
impact of comorbidity by adding the number of comor-
bidities to the number of daily drugs [33]. Different 
thresholds have been used, but often a CPS score of < 8 
has been considered to be categorized as minor, 8–14 
as moderate and ≥ 15 as major comorbidity. In our 
cohort the median CPS value was 10, and 22% had a 
CPS ≥ 15. We have not found data from its previous use 
in ICU patients, but using the CPS in geriatric trauma 
(age ≥ 65  years), the investigators found CPS to pre-
dict mortality better than the more traditional Charl-
son Comorbidity Index (CCI) [34]. Other studies have 
found the CPS to predict hospital mortality and read-
missions [35, 36] and to predict in hospital complica-
tions in older burn patients [37]. However, in our study 
this score had no impact on outcome prediction.
Our main aim was to document the impact from the 
clinical situation present before ICU admission on out-
come in very old ICU patients. Such knowledge could 
support the important clinical decision of pre-ICU tri-
age: Will this patient benefit from being admitted to the 
ICU? [21]. Despite associations between the geriatric 
syndromes and outcome, we will probably not be able 
to answer this important question just by using evalua-
tion tools and measurement. Often the patient is admit-
ted to the ICU in order to observe response to initial 
treatment. Important information related to survival 
can also be found during the first 48–72 h in the ICU. 
Hence the degree of organ dysfunction and vital organ 
support could be highly relevant due to what frequently 
is called the “in ICU triage”. Such an evaluation, formal 
or informal, often leads to treatment being withheld 
and/or withdrawn. As a matter of fact, LST limitations 
occurred in 34.4% of the patients. Severity (SOFA) and 
also frailty were independent factors predicting deci-
sion to limit LST. In the Ethicus-2 study, LST limita-
tions were documented in 13.1%, but the patients were 
younger (median 70 years) and age was found to be one 
of the determinants for EOL decision [38].
In our study, some form of organ support was given 
in 80% of all ICU admissions, most often as ventilator 
Fig. 1 Principal component analysis (PCA). Two-dimensional 
projection of the sample was constructed having the axes (principal 
components, PC) as the factors. Each PC is a linear combination of the 
original variables and PCs are orthogonal to each other. The angles 
between the vectors tell us how variables correlate with one another: 
when two vectors are close, forming a small angle, the two variables 
they represent are positively correlated. If they meet each other at 
90 °, they are not likely to be correlated and when they diverge and 
form a large angle (close to 180 °), they are negatively correlated. The 
length of the vector shows how much weight a specific variable has 
on each principal component
65
and cardiovascular support. This indicates that in most 
of the cases, there is no therapeutic limitation, and the 
very old ICU patients in our study were given active 
organ support when admitted to an ICU.
Strengths and limitations
The main strength of this study is the number of par-
ticipants derived from several European countries, with 
different cultural and legal settings, and the prospective 
multicenter observation study design using the same def-
initions of the geriatric syndromes. Limitation of LST is 
common practice in most ICUs in Europe and contrib-
utes to the observed mortality. Patients with such deci-
sion differ from other patients (Table  4), but excluding 
those patients would introduce a bias to this “real life” 
observational study. When LST limitation was included 
in the multivariable model, CFS still has a prognos-
tic impact on survival. The study was conducted within 
1  year. Hence, we assume that trends in time do not 
influence the external validity. An unforeseen limita-
tion was a huge delay in ethical and regulatory clearance 
in many countries caused by the General Data Protec-
tion Regulation (GDPR) introduced in all EU countries 
from May 2018. This made the actual recruitment period 
shorter for many ICUs. However, when comparing ICU 
with short versus long recruitment period, the patients’ 
characteristics were very similar (see ESM 8). The esti-
mated percentage of included patients to the potential 
candidates was 71.7% (ESM 9), but patients’ characteris-
tics were different in countries with a need for informed 
consent compared to patients enrolled in countries with 
no-informed consent (ESM10). This study did not focus 
on pre-ICU triage, and hence we cannot exclude some 
selection bias, in particular given the high number of 
patients living in their own home prior to admission. ICU 
triage has been the focus of other studies [39]. There is 
only scarce evidence of the inter-rater variability of the 
CFS between the caregiver and the patient when the 
Fig. 2 Adjusted survival curves according to geriatric symptoms: Adjusted survival curves for geriatric variables were produced using an inverse 
probability-weighted Kaplan–Meier estimation [19]. Variables used to adjust the curves were age, gender, place of living, reason for ICU admission 
and SOFA score. Significance was tested using a Cox regression model weighted by the same weights (inverse probability-weighted Cox). a Survival 
curves according to CFS. b Survival curves according to Katz ADL. c Survival curves according to IQCODE. d Survival curves according to CPS
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CFS is performed at the same time. However, one study 
concluded that CFS scores can be reliably assigned retro-
spectively [40] and another study, comparing CFS using 
different assessors, concluded that “CFS scores can be 
generated using medical chart review and can be reli-
ably completed by ICU clinicians and research staff“ [41]. 
Inter-rater was excellent in our study with a weighted 
kappa above 0.8. The IQCODE was missing in 24% and 
was based on informant data collected in a life-threaten-
ing situation suggesting that it is not a good tool for criti-
cally ill patients.
Another limitation is the lack of other explanatory vari-
ables like individual socio-economic status, education 
and the absence of delirium evaluation on admission and 
during the ICU stay. We focused on mortality but other 
outcomes such as long-term ventilation, chronic critical 
illness and cognitive dysfunction which are patient-rele-
vant outcomes should also be assessed in future studies.
Conclusions
We found that Clinical frailty scale alone was an inde-
pendent prognostic factor for 1-month survival after 
ICU admission. Adding other geriatric syndromes and 
Table 6 Multivariable analysis (Cox regression analysis)
HR gives the change in risk of death per each unit increase for continuous variables and for one specific category versus a reference category for categorical variables. 
HR > 1 suggests an increase in the risk of death, HR < 1 suggests a decrease in the risk of death
SOFA sequential organ failure assessment, CFS clinical frailty scale, IQCODE informant questionnaire on cognitive decline in the elderly, ADL activity of daily living, CPS 
Co-morbidity and Polypharmacy score
AIC Akaike’s information criterion. AIC was used across imputations to evaluate the goodness of fit of our models. AIC = − 2 Log likelihood + 2p, where p is the number 
of parameters
Variables Categories ALL covariates CFS Katz IQ code
HR (95%CI) p‑value HR (95%CI) p‑value HR (95%CI) p‑value HR (95%CI) p‑value








(ref = not 
home)




























Emergency surgery 0.64 (0.52–
0.78)
< 0.0001 0.64 (0.52–
0.78)
< 0.0001 0.64 (0.52–
0.78)



























0.03 0.8 (0.66–0.97) 0.02 0.79 (0.66–
0.96)
0.016













0.0003 0.71 (0.59-0.86) 0.0003 0.72 (0.6-0.87) 0.0005 0.71 (0.59-0.86) 0.0004
SOFA One-point increase 1.15 (1.14–
1.17)
< 0.00001 1.15 (1.14–
1.17)
< 0.00001 1.15 (1.14–
1.17)
<  0.001 1.15 (1.14-1.17) < 0.00001
CPS One-point increase 1 (0.99–1.01) 0.75 1 (0.99–1.01) 0.74 1 (0.99–1.01) 0.65 1.01 (1-1.02) 0.28
CFS One point increase 1.1 (1.05–1.15) 0.0001 1.12 (1.09–
1.15)
< 0.00001
Katz One point increase 0.98 (0.94–
1.02)
0.40 0.93 (0.9–0.95) < 0.00001





Mean AIC across 
imputations
23,993.92 23,991.31 24,016.93 24,025.87
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scores did not improve the model. This is an important 
finding suggesting that collection of only one score is 
feasible in circumstances of rapid processing of the 
decision making to admit or refuse an old patient in 
ICU. Predicting the future, look at the past! [42].
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Table 7 Multivariable analysis including life‑sustaining treatment limitation
Variables Categories HR (95%CI) p‑value
Age One-point increase 1 (0.99–1.02) 0.79
Habitat (ref = not home) Own home 0.96 (0.85–1.08) 0.47
Gender (ref = male) Female 0.94 (0.84–1.04) 0.24
Reason for admission (ref = circulatory 
failure)
Combined respiratory/circulatory failure 1.13 (0.94–1.36) 0.19
Emergency surgery 0.68 (0.56–0.84) 0.0003
Multitrauma w/wo head injury 1.21 (0.85–1.73) 0.28
Multitrauma without head injury 0.91 (0.61–1.36) 0.64
Other 0.88 (0.73–1.06) 0.18
Respiratory failure 0.82 (0.69–0.97) 0.021
Sepsis (according to Sepsis3) 0.67 (0.55–0.81) 0.0003
SOFA One-point increase 1.16 (1.14–1.17) < 0.0001
CPS One-point increase 0.99 (0.98–1) 0.05
CFS One-point increase 1.08 (1.05–1.12) < 0.0001
Withholding or withdrawal Yes vs no 4.25 (3.8–4.74) < 0.0001
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